| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2024-02-13 | GENERAL ATLANTIC, L.P. | Royalty Pharma plc | 26,259,141 | 5.6% | EDGAR |
| SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | Royalty Pharma plc | 37,997,522 | 8.5% | EDGAR |
| SC 13G/A | 2024-02-09 | FMR LLC | Royalty Pharma plc | 31,583,926 | 7.1% | EDGAR |
| SC 13G/A | 2024-02-09 | MORGAN STANLEY | Royalty Pharma plc | 41,159,749 | 9.2% | EDGAR |
| SC 13G/A | 2023-02-13 | GENERAL ATLANTIC, L.P. | Royalty Pharma plc | 26,244,741 | 5.6% | EDGAR |
| SC 13G/A | 2023-02-10 | MORGAN STANLEY | Royalty Pharma plc | 43,775,398 | 9.9% | EDGAR |
| SC 13G/A | 2023-02-09 | FMR LLC | Royalty Pharma plc | 44,110,365 | 10.0% | EDGAR |
| SC 13G/A | 2023-02-09 | ADAGE CAPITAL PARTNERS GP, L.L.C. | Royalty Pharma plc | 7,000,000 | 1.6% | EDGAR |
| SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | Royalty Pharma plc | 35,627,791 | 8.1% | EDGAR |
| SC 13D/A | 2022-10-04 | Giuliani Mario Germano | Royalty Pharma plc | 11,604,660 | 2.7% | EDGAR |
| SC 13D/A | 2022-08-11 | Giuliani Mario Germano | Royalty Pharma plc | 12,604,660 | 2.9% | EDGAR |
| SC 13D/A | 2022-04-05 | Giuliani Mario Germano | Royalty Pharma plc | 12,604,660 | 2.9% | EDGAR |
| SC 13G/A | 2022-02-10 | MORGAN STANLEY | Royalty Pharma plc | 56,011,010 | 13.0% | EDGAR |
| SC 13G/A | 2022-02-10 | ADAGE CAPITAL PARTNERS GP, L.L.C. | Royalty Pharma plc | 24,842,715 | 5.8% | EDGAR |
| SC 13G | 2022-02-10 | VANGUARD GROUP INC | Royalty Pharma plc | 29,636,565 | 6.9% | EDGAR |
| SC 13G/A | 2022-02-09 | FMR LLC | Royalty Pharma plc | 22,079,795 | 5.1% | EDGAR |
| SC 13G | 2021-02-16 | GENERAL ATLANTIC LLC | Royalty Pharma plc | 26,243,870 | 6.4% | EDGAR |
| SC 13G/A | 2021-02-11 | ADAGE CAPITAL PARTNERS GP, L.L.C. | Royalty Pharma plc | 38,714,280 | 10.0% | EDGAR |
| SC 13G/A | 2021-02-10 | MORGAN STANLEY | Royalty Pharma plc | 46,144,883 | 11.9% | EDGAR |
| SC 13G | 2021-02-09 | MORGAN STANLEY | Royalty Pharma plc | 23,597,287 | 6.1% | EDGAR |